These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21884695)

  • 1. Quantitative analysis of multiple methylated genes in plasma for the diagnosis and prognosis of hepatocellular carcinoma.
    Huang ZH; Hu Y; Hua D; Wu YY; Song MX; Cheng ZH
    Exp Mol Pathol; 2011 Dec; 91(3):702-7. PubMed ID: 21884695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative methylation analysis of multiple genes using methylation-sensitive restriction enzyme-based quantitative PCR for the detection of hepatocellular carcinoma.
    Hua D; Hu Y; Wu YY; Cheng ZH; Yu J; Du X; Huang ZH
    Exp Mol Pathol; 2011 Aug; 91(1):455-60. PubMed ID: 21600201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of tumor associated genes in tissue and plasma samples from liver disease patients.
    Chang H; Yi B; Li L; Zhang HY; Sun F; Dong SQ; Cao Y
    Exp Mol Pathol; 2008 Oct; 85(2):96-100. PubMed ID: 18691570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.
    Lee S; Lee HJ; Kim JH; Lee HS; Jang JJ; Kang GH
    Am J Pathol; 2003 Oct; 163(4):1371-8. PubMed ID: 14507645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is serum level of methylated RASSF1A valuable in diagnosing hepatocellular carcinoma in patients with chronic viral hepatitis C?
    Mohamed NA; Swify EM; Amin NF; Soliman MM; Tag-Eldin LM; Elsherbiny NM
    Arab J Gastroenterol; 2012 Sep; 13(3):111-5. PubMed ID: 23122451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
    Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
    Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.
    Yeo W; Wong N; Wong WL; Lai PB; Zhong S; Johnson PJ
    Liver Int; 2005 Apr; 25(2):266-72. PubMed ID: 15780049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The assessment of methylated BASP1 and SRD5A2 levels in the detection of early hepatocellular carcinoma.
    Tsunedomi R; Ogawa Y; Iizuka N; Sakamoto K; Tamesa T; Moribe T; Oka M
    Int J Oncol; 2010 Jan; 36(1):205-12. PubMed ID: 19956849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
    Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
    Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
    Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.
    Hoque MO; Feng Q; Toure P; Dem A; Critchlow CW; Hawes SE; Wood T; Jeronimo C; Rosenbaum E; Stern J; Yu M; Trink B; Kiviat NB; Sidransky D
    J Clin Oncol; 2006 Sep; 24(26):4262-9. PubMed ID: 16908936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.
    Li B; Liu W; Wang L; Li M; Wang J; Huang L; Huang P; Yuan Y
    Ann Surg Oncol; 2010 Jul; 17(7):1917-26. PubMed ID: 20112070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylated cyclin D2 gene circulating in the blood as a prognosis predictor of hepatocellular carcinoma.
    Tsutsui M; Iizuka N; Moribe T; Miura T; Kimura N; Tamatsukuri S; Ishitsuka H; Fujita Y; Hamamoto Y; Tsunedomi R; Iida M; Tokuhisa Y; Sakamoto K; Tamesa T; Sakaida I; Oka M
    Clin Chim Acta; 2010 Apr; 411(7-8):516-20. PubMed ID: 20064498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.
    Yamamoto N; Nakayama T; Kajita M; Miyake T; Iwamoto T; Kim SJ; Sakai A; Ishihara H; Tamaki Y; Noguchi S
    Breast Cancer Res Treat; 2012 Feb; 132(1):165-73. PubMed ID: 21594664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma.
    Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC
    Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
    Zhang C; Li Z; Cheng Y; Jia F; Li R; Wu M; Li K; Wei L
    Clin Cancer Res; 2007 Feb; 13(3):944-52. PubMed ID: 17289889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma.
    Schagdarsurengin U; Wilkens L; Steinemann D; Flemming P; Kreipe HH; Pfeifer GP; Schlegelberger B; Dammann R
    Oncogene; 2003 Mar; 22(12):1866-71. PubMed ID: 12660822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of RASSF1A promoter methylation in hepatocellular carcinoma and its prognostic implications.
    Xu B; Di J; Wang Z; Han X; Li Z; Luo X; Zheng Q
    Biochem Biophys Res Commun; 2013 Aug; 438(2):324-8. PubMed ID: 23891693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.